Environmental Transmission of Clostridium difficile: Association between Hospital Room Size and C. difficile Infection

Infection Control and Hospital Epidemiology

Volumn 36, Issue 5, 2015, Pages 564-568

  Jou, Justine ^a   Ebrahim, John ^c   Shofer, Frances S ^a   Hamilton, Keith W ^a   Stern, John ^a   Han, Jennifer H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CLINDAMYCIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; UNIVERSITY HOSPITAL; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEALTH CARE FACILITY; HOSPITAL DESIGN; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

AGED; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITAL DESIGN AND CONSTRUCTION; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENTS' ROOMS; RISK FACTORS;

EID: 84994235464     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.18     Document Type: Article

References (30)

1. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010;31:1030-1037.
2. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009;37:263-270.
3. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012;55(suppl 2):S88-92.
4. Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med 2014;30:79-93.
5. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007;8:290-299.
6. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1-15.
7. Haines CF, Moore RD, Bartlett JG, et al. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes. AIDS 2013;27:2799-2807.
8. Shah SA, Tsapepas DS, Kubin CJ, et al. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation. Transpl Infect Dis 2013;15:502-509.
9. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008;70:298-304.
10. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012;67:742-748.
11. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143:42-50.
12. Faires MC, Pearl DL, Berke O, Reid-Smith RJ, Weese JS. The identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment. BMC Infect Dis 2013;13:342.
13. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 2013;26:338-344.
14. Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008;46:447-450.
15. Gerding DN, Muto CA, Owens RC, Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 46(suppl 1):S43-49.
16. Vardakas KZ, Konstantelias AA, Loizidis G, Rafailidis PI, FalagasME. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis 2012;16: e768-773.
17. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53:42-48.
18. Rutala WA, Weber DJ. Disinfectants used for environmental disinfection and new room decontamination technology. Am J Infect Control 2013;41(suppl):S36-41.
19. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011;32:201-206.
20. Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000;31:717-722.
21. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-145.
22. Weber DJ, Rutala WA. The role of the environment in transmission of Clostridium difficile infection in healthcare facilities. Infect Control Hosp Epidemiol 2011;32:207-209.
23. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32-40.
24. Carling PC, Parry MM, Rupp ME, et al; Healthcare Environmental Hygiene Study Group Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol 2008;29:1035-1041.
25. Goodman ER, Platt R, Bass R, Onderdonk AB, Yokoe DS, Huang SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008;29: 593-599.
26. Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010;10:197.
27. Boyce JM, Havill NL, Otter JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008;29:723-729.
28. Chopra T, Alangaden GJ, Chandrasekar P. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 2010;8:1113-1119.
29. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993;17: 109-113.
30. Collini PJ, Bauer M, Kuijper E, Dockrell DH. Clostridium difficile infection inHIV-seropositive individuals and transplant recipients. J Infect 2012;64:131-147.